.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Colorcon
Harvard Business School
Julphar
Queensland Health
Daiichi Sankyo
Argus Health
Cantor Fitzgerald
Mallinckrodt
Johnson and Johnson

Generated: December 18, 2017

DrugPatentWatch Database Preview

CARDENE SR Drug Profile

« Back to Dashboard

When do Cardene Sr patents expire, and what generic alternatives are available?

Cardene Sr is a drug marketed by Chiesi Usa Inc and is included in one NDA.

The generic ingredient in CARDENE SR is nicardipine hydrochloride. There are eleven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chiesi Usa IncCARDENE SRnicardipine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL020005-001Feb 21, 1992DISCNYesNo► Subscribe► Subscribe► Subscribe
Chiesi Usa IncCARDENE SRnicardipine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL020005-002Feb 21, 1992DISCNYesNo► Subscribe► Subscribe► Subscribe
Chiesi Usa IncCARDENE SRnicardipine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL020005-003Feb 21, 1992DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: CARDENE SR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Chiesi Usa IncCARDENE SRnicardipine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL020005-003Feb 21, 1992► Subscribe► Subscribe
Chiesi Usa IncCARDENE SRnicardipine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL020005-001Feb 21, 1992► Subscribe► Subscribe
Chiesi Usa IncCARDENE SRnicardipine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL020005-003Feb 21, 1992► Subscribe► Subscribe
Chiesi Usa IncCARDENE SRnicardipine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL020005-002Feb 21, 1992► Subscribe► Subscribe
Chiesi Usa IncCARDENE SRnicardipine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL020005-002Feb 21, 1992► Subscribe► Subscribe
Chiesi Usa IncCARDENE SRnicardipine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL020005-001Feb 21, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Daiichi Sankyo
Accenture
Teva
Novartis
McKinsey
Moodys
Medtronic
Deloitte
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot